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as not exposed to allopurinol for 121 days (which contains 30 days grace period 
for refilling and 91 days for washout RESULTS: In multivariable-adjusted that 
adjusted for all factors except medication and disease severity factors (model 5), 
we found that the following factors were significantly associated with higher odds 
of allopurinol MPR ≥ 80%: older age, Caucasian race, being currently married; gout 
care from primary care provider specialty, smaller facility bed size, community-
based outpatient clinic and Midwest location; means test, service connection ≥ 50% 
and longer distance to the nearest VA. Higher BMI had a non-significant trend 
towards higher odds of allopurinol MPR ≥ 80%. CONCLUSIONS: In this study, we 
identified several novel factors associated with allopurinol adherence. This new 
knowledge can be used to improve the likelihood of success of lowering serum 
urate with allopurinol pharmacotherapy by targeting modifiable risk factors iden-
tified in our study.
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OBJECTIVES: To compare the effect on metabolic control between conventional 
and analogues insulins. METHODS: Retrospective cohort study in primary care 
centers in cities of Pereira and Manizales from Colombia. Monitoring period 
18 months to patients diagnosed with diabetes mellitus type 1 and 2 selected 
by stratified random sampling, of pay regime members of the Health System 
of Colombia, treated with conventional and analogues insulins (glargine, gluli-
sine, aspartate, detemir) for at least 6 months. Collecting data from the clinical 
records and analytical results for each patient. Comparison groups according to 
the type of insulin received were created (insulin glargine vs NPH; NPH / glargine 
vs regular / glulisine). Primary and secondary variables: initial HbA1c measure-
ment and comparison at 6 months and 3 and 18 months respectively. RESULTS: 
313 patients were included with a mean age of 57.3 years and 56.9% were female. 
No statistically significant difference in reducing glycosylated hemoglobin at 3, 
6 and 18 months comparing groups insulin glargine vs NPH (p = 0.403) and NPH/
glargine vs regular/glulisine (p = 0.514) were observed. The percentage of patients 
with metabolic control increased from 27.8% to 34.2% during follow-up with all 
insulins. CONCLUSIONS: We did not find that analogue insulins were superior to 
human in glycemic control effect and a high percentage of patients did not meet 
the recommended treatment, which requires implement measures to improve the 
monitoring and control of diabetes mellitus.
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OBJECTIVES: To understand NHS hospital activity associated with Tuberous 
Sclerosis Complex (TSC) management, and support the development of specialised 
commissioned services in England. METHODS: Hospital Episode Statistics (HES) 
data for patients with TSC (ICD-10 code Q85.1, recorded between 2006-2013) were 
extracted in July 2014. Hospital visits and admissions occurring in 2013 were ana-
lysed nationally, at 14 ‘hub’ hospitals and at the top-five most frequently accessed 
‘spoke’ hospitals. RESULTS: Since 2006, 1922 patients were coded with TSC; age 
distribution 46% < 18 years, 54% > 18 years. In 2013 the most common TSC-associated 
conditions were epilepsy (n= 1101), developmental disorder (n= 485), benign lipo-
matous neoplasms (n= 160), childhood autism (n= 141), other convulsions (n= 60). 
615 patients attended for outpatient appointments in 2013 (all indications). There 
were 0.8 elective and 1.9 non-elective admissions/patient (n= 489 and 1180/615, 
respectively). Elective admissions averaged 3.9 bed-days per patient, with 4.2 bed-
days/admission for non-elective admissions. There were 1.9 day-case (1193/615) 
and 9.6 outpatient (5899/615) visits/patient. Of 5899 outpatient attendances, the 
top five specialties were paediatrics (17%), paediatric neurology (9%), neurology (6%) 
nephrology (5%) and ophthalmology (5%). In the ‘hub’ hospitals there were 5.4 out-
patient visits/patient, with the top five specialties being paediatric neurology (12%), 
paediatrics (6%), nephrology (6%), neurology (4%), paediatric nephrology (4% In the 
spoke providers, the top-five outpatient specialties (n= 1564 visits) were paediatrics 
(21%), learning disability (11%), neurology (8%), paediatric neurology (7%) and oph-
thalmology (6%). CONCLUSIONS: The prevalence of TSC was lower than expected, 
possibly an artefact of inappropriate NHS coding. TSC management is intensive 
with many outpatient/day-case visits, and non-elective admissions. Patients are 
also likely to be receiving care in the community, in addition to the hospital activ-
ity reported. TSC management is unevenly distributed between ‘hub’ and ‘spoke’ 
hospitals. Differentiated paediatric and adult services are needed. Fragmentation 
of TSC service provision suggests specialist management is needed, with coordina-
tion by specialist providers.
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OBJECTIVES: Worldwide, cigarette Smoking is responsible for more than 5 million 
deaths and is expected to exceed 8 million by 2030. The objective of this study was 
to identify predictors of smoking in China India and Taiwan. METHODS: A cross-
sectional study was conducted in convenient sample of adults using a pretested and 
validated questionnaire between 2008-2011 in China, India and Taiwan. Smoking 
status was ascertained among participants through one question inquiring if they 
had smoked cigarette within last 30days. RESULTS: A total of 2397 questionnaires 
(ED) from January 2013 to August 2014 with confirmed dengue test. Analyses were 
made in three steps: results description; agreement analysis with Kappa test; and 
several regression analyses. Outcome (severe dengue) was defined as critical care 
entrance. RESULTS: 761 children with confirmed dengue were analyzed. 50.6% were 
male, 67.2% stayed more than one day in the hospital. Median age was 7.9 years (IQR, 
5.0-10.7). Kappa statistics between the two definitions for hospitalized patients (n 
= 504) was 0.30 (standard error= 0.04). 137 (18%) patients were admitted with DHF/
DSS, according to WHO 1997. DHF/DSS had a sensitivity of 33.3% (95% CI, 30.0-36.7) 
and specificity of 83.2% (95% CI, 80.5-85.8) in inpatient with severe dengue. Adjusted 
binomial regression showed a relative risk of 2.3 (95% CI, 1.3-3.9) for the outcome 
in patients with DHF/DSS. WHO 2009 definition showed a sensitivity of 31.5% (95% 
CI, 28.2-34.8) and specificity of 94.3% (95% CI, 92.7-96.0). Median number of warn-
ing sign at emergency admission was 2 (IQR, 1-2). Number of warning signs was 
significantly different between patients who entered critical care versus patients 
who did not (P< 0.001). CONCLUSIONS: The WHO 2009 showed significant over-
perfomance compared WHO 1997.
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OBJECTIVES: Medication adherence among hypertensive patients is poor stemming 
from various factors. The aim of this review was to appraise published randomized 
control trials (RCTs) on hypertensive patients to determine the effectiveness of a 
pharmacist led intervention for improving medication adherence and blood pres-
sure control. METHODS: Only English language RCTs published between January 
1st, 1995 and December 31st, 2013 were considered for inclusion. Electronic data-
bases searched included: PubMed, Web of Science, Elsevier, CINAHL, and Google 
Scholar. Studies were eligible if they comprised a separate group of controls. The 
intervention, pharmaceutical care or counseling provided by a pharmacist, had 
to be compared with the usual treatment for hypertension or a combination of 
usual treatment and sham interventions. Only studies that compared outcomes 
after at least a six month follow up period using at least one or a combination of 
the following for assessing adherence: pill count, medication refill rate, or a vali-
dated adherence scale were included. RESULTS: Of 457 citations reviewed, 9 RCTs 
met the inclusion criteria. The included RCTs were conducted in various parts of 
the world, including China, Brazil, Portugal and the United States. Across the 9 
RCTs, a total of 581 individuals for the intervention group and 587 individuals in 
the control group were compared in the analyses. The outcome measures were 
systolic and diastolic blood pressure, and medication adherence assessed using a 
validated tool. The results showed that for the intervention group, which received 
pharmaceutical care services, there was a significant decline in systolic and diastolic 
blood pressure and improved medication adherence from baseline, in comparison 
to the control group. CONCLUSIONS: Pharmaceutical care may improve adherence 
and blood pressure control in hypertensive individuals. The evidence supports the 
wider provision of pharmaceutical care for hypertension management in various 
practice settings.
PHS10
effeCtS of SoCial networkS on Patient adHerenCe to PreSCribed 
treatment for SeriouS mental illneSS: a SyStematiC review
LyttleNguessan C.J., Campbell E.S.
Florida A&M University, Tallahasse, FL, USA
OBJECTIVES: Mental illness is a global public health concern with clinical and 
economical burden. Medication non-adherence increases the risk outcomes (e.g. 
relapse, re-hospitalization and delayed illness recovery) of mental health care. The 
purpose of this study was to determine the effects (positive, negative or none) of 
social networks on patient adherence to prescribed treatment for serious mental ill-
ness (SMI). METHODS: We systematically reviewed studies published from January 
2003 to December 2012. We evaluated five established social network interventions 
(education and behavioral support, social support, collaborative care; case man-
agement, care management) with three outcomes (improved patient adherence 
to prescribed mental health treatment protocol, hindered/impeded patient adher-
ence to prescribed mental health treatment protocol & no effect on patient adher-
ence to prescribed mental health treatment protocol). We assessed the number of 
studies that reported improved, hindered or no effect outcome by summarizing 
the studies and listing their main outcomes. We also assessed the quality of the 
studies by checking yes (or no) whether they met methodological quality criteria, 
and assigned a percentage score that indicated the strength of quality. Quality 
was based on reporting and design standards and statistical soundness. RESULTS: 
Thirteen studies met the inclusion criteria of enrolling patients suffering from SMI 
and reporting effects of social network relating to patient adherence to prescribed 
mental healthcare treatment. Nine studies reported improved, three reported no 
effect and only one reported hindered outcome. All studies met the general quality 
criteria but their strength varied. CONCLUSIONS: The findings indicate that social 
networks improved patient adherence to prescribed mental illness treatment but 
there are limitations to these findings. The potential for publication bias under-
scores the need to more closely examine the results of evidence-based research.
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OBJECTIVES: To assess the factors associated with high allopurinol adher-
ence. METHODS: Allopurinol prescription was defined as at least 30 days of a 
filled allopurinol prescription. Patients were censored when they switched from 
allopurinol to one of the other ULT. Index allopurinol prescription was defined 
